Malaria: A Sneaky Challenger
An insight into malaria's tactics and our immune response.
Sukai Ceesay, Martin Kampmann, Lasse Votborg-Novél, Helle Smedegaard Hansson, Rasmus Weisel Jensen, Manuela Carrasquilla, Hamidou Cisse, Louise Turner, Usama Dabbas, Christina Ntalla, Silke Bandermann, Safiatou Doumbo, Didier Doumtabe, Aissata Ongoiba, Kassoum Kayentao, Boubacar Traore, Peter D Crompton, Thomas Lavstsen, Silvia Portugal
― 6 min read
Table of Contents
Malaria is a disease caused by parasites that are spread through the bites of infected mosquitoes. The major parasite responsible for malaria is Plasmodium Falciparum. This little troublemaker is a big deal globally, causing around 300 million cases of malaria and leading to about 500,000 deaths every year, with young children in Africa being the most affected.
The life-cycle of malaria involves several stages, making it a complex and challenging disease. Once a person is bitten by an infected mosquito, the parasites invade their bloodstream, multiply, and can cause severe illness.
How Malaria Evades the Body's Defenses
Plasmodium falciparum has a clever trick up its sleeve to stick around in the body longer than it should. It can change its outer surface proteins, known as variant surface antigens (VSAs). In particular, it uses a protein called PfEMP1 to cling to the blood vessels inside the body. By doing this, it can escape being cleared out by the body's immune system, which usually targets and removes infected cells.
As the parasites continue to multiply, they can cause severe symptoms. The clingy nature of PfEMP1 allows the infected red blood cells (called iRBCs) to get stuck in places they shouldn't, leading to blockages in blood flow and inflammation.
The Many Faces of Plasmodium falciparum
This sneaky parasite comes with a massive arsenal. Each parasite has about 60 different Var Genes responsible for producing the various PfEMP1 proteins. These proteins can change so that the immune system has a harder time recognizing and fighting them off. This is a bit like a magician changing their costume while trying to escape from a locked box.
The var genes can be quite similar to each other, but they vary enough to trick the immune system into thinking it's dealing with different invaders every time. These genes can shuffle and mutate, creating new variants that help the parasites stay one step ahead. They also come in different flavors, which determines how they behave when they latch onto blood vessels.
Seasonal Patterns of Malaria
In many places where malaria is common, the disease follows a seasonal pattern. This means that during certain times of the year, when mosquitoes are more active due to favorable weather conditions, malaria cases spike. During the drier parts of the year, cases of malaria drop significantly.
Even during the dry months, though, some people can carry the parasites without showing any symptoms. These asymptomatic carriers can serve as carriers for the infection, allowing it to explode back into the population when the wet season arrives. It’s like having a secret stash of cupcakes that you save for the next party.
Observing Malaria in Mali
In a study conducted in Mali, researchers looked at both symptomatic and asymptomatic malaria cases throughout different seasons. They gathered samples from numerous individuals and checked how the var genes expressed themselves in the different conditions.
They found that during the dry season, there were fewer parasites active in the blood of those who were asymptomatic. These people showed a limited number of different variants compared to those with symptomatic malaria during the wet season.
What the Study Found
The results of the study indicated that the parasites in people experiencing symptoms were expressing many more var genes compared to those who were asymptomatic. This makes sense because symptomatic cases need to fight harder to avoid being cleared by the immune system.
Interestingly, the variety of PfEMP1 proteins expressed in those with clinical cases was much higher. Asymptomatic individuals had a few, dominant proteins that made them less likely to have severe responses. Think of it as a game of hide and seek – the less variety, the easier it is to go unnoticed by the immune system.
Discussing the Data
Researchers also noted that younger individuals were more commonly seen with active malaria cases while older individuals tended to show asymptomatic infections. This suggests that with age comes a better immune response, potentially due to a history of exposure to the parasites.
The study measured the infection intensity in the blood and found that symptomatic infections showed higher parasite counts. This was true across all study periods, confirming that clinical cases of malaria are indeed a lot more intense than the sneaky, silent infections.
Antibodies
The Importance ofAnother fascinating aspect of the research looked at antibodies, which are like the body’s little soldiers fighting off the parasites. People with asymptomatic infections had more experience with the parasite due to repeated infections and thus had higher levels of antibodies. This probably helps them keep the parasites at bay, preventing severe symptoms.
Moreover, those with more antibodies found it easier to recognize and respond to the Plasmodium falciparum parasites when they appeared. This goes to show that having a good memory of your enemy can be quite helpful in a fight.
The Role of Mosquitoes
The types of mosquitoes that spread malaria love to breed in standing water. During the dry season, when there’s less water around, the mosquitoes have a harder time. This is why malaria cases often drop in those months. However, during the rainy season, the party starts again, and infected mosquitoes can readily spread the infection.
The scientists also observed that the parasites can survive in asymptomatic carriers for long stretches. This is quite important, as it provides a reservoir that helps the infection return each wet season. Think of it as a game of tag where the tagged players try to hide until they can resume playing.
The Measures Taken
In order to understand how the Plasmodium falciparum behaves in different individuals with varying levels of immunity, researchers used a variety of methods such as sequencing techniques to analyze the changes in var gene expression. They looked at how many variants were present and how the immune system responded to these variations.
This analysis helped paint a clearer picture of how the parasite is evading immune detection and how the immune system is trying to catch up with it.
Conclusion
The research around malaria emphasizes both the complexity of the parasite and the immune response of humans. It highlights the importance of studying how these two interact, especially during different seasons of infection.
The findings revealed that people who have repeated exposures to malaria become like seasoned players in a game, better at avoiding the severe consequences of the infection. While there is still much to learn about this subtle and dangerous disease, one thing is for sure – Plasmodium falciparum is one of humanity's most cunning opponents in the game of survival.
With ongoing research and a better understanding of malaria's tactics, we may find some winning strategies to keep it at bay and protect vulnerable populations, especially the little ones who are so often affected. Until then, it looks like the game is still on!
Original Source
Title: Plasmodium falciparum expresses fewer var genes at lower levels during asymptomatic dry season infections than clinical malaria cases
Abstract: In seasonal transmission areas, clinical malaria occurs during the wet season when mosquitoes are present, while in the dry season, malaria transmission is interrupted and clinical cases are rare. In Mali, Plasmodium falciparum can persist in low parasitaemic asymptomatic individuals through the six-month dry season and shows reduced cytoadhesion of infected erythrocytes, evidenced by the circulation of further developed parasite stages compared to clinical malaria cases. How prolonged circulation of infected erythrocytes is achieved remains unknown. Here, we explored var gene expression in subclinical infections and clinical malaria cases of Malian children, collected during the dry and wet seasons. We sequenced expressed var DBL-tags, used bioinformatic tools to predict their domain composition, binding phenotype and upstream sequence type; and determined their relationship to seasonality and clinical presentation. We found that parasites of asymptomatic infections expressed fewer var genes, with a larger proportion of var transcripts attributed to one or a few vars. In contrast, clinical cases exhibited expression of many var genes at lower proportions. We found that parasites of asymptomatic carriers expressed a mixture of CD36- and EPCR-binding PfEMP1, which changed over time. We confirmed that vars encoding CD36-binding PfEMP1 dominated in non-severe malaria cases, and found no significant difference in expressed var types between dry and wet seasons. Asymptomatic carriers were older, had higher titers of anti-P. falciparum antibodies, and broader reactivity to PfEMP1, suggesting that host immunity was the main determinant limiting var transcript variation in asymptomatic carriers. However, by RNAseq and qRT-PCR we also observed significantly higher total var transcript levels in malaria cases compared to asymptomatic carriers, suggesting that in addition to the parasites switching and the hosts immune selection of expressed var genes, parasites able to sustain long-term infections may be poised for reduced PfEMP1 expression.
Authors: Sukai Ceesay, Martin Kampmann, Lasse Votborg-Novél, Helle Smedegaard Hansson, Rasmus Weisel Jensen, Manuela Carrasquilla, Hamidou Cisse, Louise Turner, Usama Dabbas, Christina Ntalla, Silke Bandermann, Safiatou Doumbo, Didier Doumtabe, Aissata Ongoiba, Kassoum Kayentao, Boubacar Traore, Peter D Crompton, Thomas Lavstsen, Silvia Portugal
Last Update: 2024-12-30 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.30.630752
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.30.630752.full.pdf
Licence: https://creativecommons.org/publicdomain/zero/1.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.